Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Aug 31, 2025 | (Q4)Aug 31, 2025 | (Q3)May 31, 2025 | (Q2)Feb 28, 2025 | (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -2.00%225.12M | -8.85%51.51M | -8.93%56.35M | -3.42%55.6M | 14.69%61.66M | 41.24%229.72M | 22.80%56.51M | 63.34%61.88M | 44.64%57.57M | 38.06%53.76M |
| Cost of revenue | -0.10%107.5M | 45.58%107.6M | ||||||||
| Gross profit | -3.68%117.62M | 37.63%122.12M | ||||||||
| Operating expense | 3.63%87.18M | -5.58%44.71M | -1.82%48.94M | 2.26%47.18M | 15.38%47.84M | 39.42%84.13M | 32.97%47.35M | 65.15%49.85M | 40.08%46.13M | 35.80%41.46M |
| Staff costs | 2.62%49.04M | ---- | ---- | ---- | ---- | 33.66%47.79M | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 2.20%5.98M | ---- | ---- | ---- | ---- | -6.20%5.85M | ---- | ---- | ---- | ---- |
| -Depreciation | 2.20%5.98M | ---- | ---- | ---- | ---- | -6.20%5.85M | ---- | ---- | ---- | ---- |
| Other operating expenses | 4.74%35.12M | -4.00%46.98M | -4.08%50.24M | 0.92%49.65M | 15.11%51.02M | 54.83%33.53M | 28.88%48.93M | 62.90%52.38M | 44.07%49.2M | 33.07%44.33M |
| Total other operating income | -2.84%2.96M | 43.30%2.27M | -48.68%1.3M | -19.34%2.47M | 11.10%3.18M | -8.03%3.04M | -32.97%1.58M | 28.35%2.53M | 152.35%3.07M | 3.09%2.87M |
| Operating profit | -19.88%30.44M | -25.72%6.8M | -38.42%7.41M | -26.34%8.43M | 12.35%13.82M | 33.81%37.99M | -12.00%9.16M | 56.25%12.03M | 66.53%11.44M | 46.27%12.3M |
| Net non-operating interest income (expenses) | -13.25%6.02M | 38.89%6.94M | ||||||||
| Non-operating interest income | -13.04%6.06M | ---- | ---- | ---- | ---- | 38.81%6.97M | ---- | ---- | ---- | ---- |
| Non-operating interest expense | 37.56%40.07K | ---- | ---- | ---- | ---- | 22.52%29.13K | ---- | ---- | ---- | ---- |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -18.86%36.46M | -25.72%6.8M | -38.42%7.41M | -26.34%8.43M | 12.35%13.82M | 34.57%44.93M | -12.00%9.16M | 56.25%12.03M | 66.53%11.44M | 46.27%12.3M |
| Income tax | -17.14%8.93M | -29.86%1.67M | -37.00%1.86M | -5.27%2.08M | 2.15%3.32M | 45.77%10.78M | -4.76%2.38M | 97.32%2.95M | 69.23%2.2M | 54.76%3.25M |
| Net income | -19.40%27.53M | -24.27%5.13M | -38.88%5.56M | -31.36%6.34M | 16.01%10.5M | 31.38%34.15M | -14.29%6.78M | 46.37%9.09M | 65.90%9.24M | 43.44%9.05M |
| Net income continuous operations | -19.40%27.53M | -24.27%5.13M | -38.88%5.56M | -31.36%6.34M | 16.01%10.5M | 31.38%34.15M | -14.29%6.78M | 46.37%9.09M | 65.90%9.24M | 43.44%9.05M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to the company | -19.40%27.53M | -24.27%5.13M | -38.88%5.56M | -31.36%6.34M | 16.01%10.5M | 31.38%34.15M | -14.29%6.78M | 46.37%9.09M | 65.90%9.24M | 43.44%9.05M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -19.40%27.53M | -24.27%5.13M | -38.88%5.56M | -31.36%6.34M | 16.01%10.5M | 31.38%34.15M | -14.29%6.78M | 46.37%9.09M | 65.90%9.24M | 43.44%9.05M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -19.00%0.0597 | -23.29%0.0112 | -38.27%0.0121 | -31.16%0.0137 | 16.41%0.0227 | 31.37%0.0737 | -14.62%0.0146 | 46.27%0.0196 | 65.83%0.0199 | 43.38%0.0195 |
| Diluted earnings per share | -19.00%0.0597 | -23.29%0.0112 | -38.27%0.0121 | -31.16%0.0137 | 16.41%0.0227 | 31.37%0.0737 | -14.62%0.0146 | 46.27%0.0196 | 65.83%0.0199 | 43.38%0.0195 |
| Dividend per share | 6.25%0.017 | 0 | 0 | 6.25%0.017 | 0 | 60.00%0.016 | 0 | 0 | 60.00%0.016 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.